NewAmsterdam Pharma Company
NAMS
#3412
Rank
โ‚ฌ3.48 B
Marketcap
30,71ย โ‚ฌ
Share price
1.39%
Change (1 day)
75.19%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2025 (TTM): -โ‚ฌ0.25 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are โ‚ฌ35.24 Million. In 2024 the company made an earning of -โ‚ฌ0.21 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.25 Billion18.63%
2024 -โ‚ฌ0.21 Billion37.74%
2023 -โ‚ฌ0.16 Billion